Forodesine in the Treatment of Cutaneous T-Cell Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

July 31, 2010

Study Completion Date

December 31, 2011

Conditions
Cutaneous T-cell Lymphoma (CTCL),
Interventions
DRUG

Forodesine 200 mg

2 x 100mg tablets once daily

Trial Locations (41)

1090

Wien, Vienna

3144

Cabrini Hospital, Malvern

10126

Torino, Torino

13210

Upstate Medical University, Syracuse

15213

Hillman Cancer Ctr., University of Pittsburgh, Pittsburgh

19104

Hospital at the University of Pennsylvania, Philadelphia

20122

Milan, Milan

24105

Universitat Kiel, Kiel

27157

Wake Forest University Health Sceinces, Dept. of Dermatology, Winston-Salem

27710

Duke University Medical Center, Durham

28041

Madrid, Madrid

30322

Emory University, Atlanta

31059

Toulouse, Toulouse

33600

Pessac, Pessac

33612

Moffitt Cancer Center, Tampa

34295

Montpellier, Montpellier

40138

Bologna, Bologna

44106

University Hospitals Case Medical Center, Dept. of Dermatology, Cleveland

44718

Gabrail Cancer Center, Canton

50121

Firenze, Florence

51092

CHU Robert Debre, Reims

53715

University of Wisconsin-Madison, Dept of Dermatology, Madison

63058

Hopital Hotel-Dieu, Clermont-Ferrand

63110

Washington University School of Medicine, St Louis

68163

Klinik fur Dermatologie, Venerologie und Allergologie, Mannheim

71103

LSU Health Sciences Center, Feist-Weiller Cancer Center, Shreveport

77030

M.D. Anderson Cancer Center - Dermatology, Houston

89109

Seattle Cancer Care Alliance, Seattle

94000

Creteil, Créteil

94305

Stanford University Medical Center, Stanford

35294-3300

University of Alabama at Birmingham, Comprehensive Cancer Ctr, Birmingham

06520

Yale Cancer Center, New Haven

02118

Boston Medical Center, Boston

07601

Hackensack University Medical Ctr, Hackensack

FIN-00029 HUS

Helsinki, Helsinki

D10117

Campus Charité Mitte, Berlin

07740

Universitatsklinikum Jena, Jena

00167

Rome, Rome

CH-8091

Zurich, Zurich

SE1 7EH

London, London

M20 4BX

Manchester, Manchester

Sponsors
All Listed Sponsors
lead

BioCryst Pharmaceuticals

INDUSTRY